Sarah Bacus
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 47
- HER2/EGFR in Cancer Research 35
- Cancer-related Molecular Pathways 7
- Cancer Treatment and Pharmacology 5
-
- Glycosylation and Glycoproteins Research 9
- PI3K/AKT/mTOR signaling in cancer 5
- Co-authors
- Yosef Yarden (15 shared papers)Ljuba Lyass (12 shared papers)Neil L. Spector (18 shared papers)Elior Peles (3 shared papers)Hsieng S. Lu (2 shared papers)Raymond A. Koski (2 shared papers)Duanzhi Wen (2 shared papers)Wenle Xia (9 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Oncogene (5 papers)Molecular Cancer Therapeutics (5 papers)Cancer Research (4 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Sarah Bacus
68 papers receiving 5.5k citations
Sarah Bacus's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 3.3k
- Radiology, Nuclear Medicine and Imaging 1.3k
- Immunology and Allergy 274
- Cancer Research 587
- Molecular Biology 2.7k
Countries citing papers authored by Sarah Bacus
This map shows the geographic impact of Sarah Bacus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Bacus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Bacus more than expected).
Fields of papers citing papers by Sarah Bacus
This network shows the impact of papers produced by Sarah Bacus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Bacus. The network helps show where Sarah Bacus may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah Bacus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit Hit paper breakdown → | 1992 | 526 |
| 2 | 1992 | 483 | |
| 3 | 2002 | 468 | |
| 4 | 2001 | 324 | |
| 5 | 2006 | 301 | |
| 6 | 2005 | 301 | |
| 7 | 2005 | 211 | |
| 8 | Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. | 1995 | 150 |
| 9 | 2013 | 143 | |
| 10 | 1998 | 141 | |
| 11 | 2010 | 140 | |
| 12 | 2006 | 128 | |
| 13 | 2007 | 125 | |
| 14 | 2002 | 124 | |
| 15 | 1996 | 123 | |
| 16 | 1998 | 121 | |
| 17 | 2013 | 118 | |
| 18 | Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients. | 2003 | 113 |
| 19 | 1990 | 107 | |
| 20 | 2004 | 99 |
About Sarah Bacus
Sarah Bacus is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics, having authored 69 papers that have together received 5.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (35 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Glycosylation and Glycoproteins Research (9 papers), Lung Cancer Treatments and Mutations (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Cancer-related Molecular Pathways (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Oncology (3.3k citations), Radiology, Nuclear Medicine and Imaging (1.3k citations), Immunology and Allergy (274 citations), Cancer Research (587 citations) and Molecular Biology (2.7k citations). Sarah Bacus has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Yosef Yarden, Ljuba Lyass, Neil L. Spector, Elior Peles, Hsieng S. Lu, Raymond A. Koski, Duanzhi Wen, Wenle Xia, Patricia B. Trusk and Khandan Keyomarsi. Their work appears in journals such as Journal of Clinical Oncology, Oncogene, Molecular Cancer Therapeutics, Cancer Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.